Dr. Steven Hochwald to usher in new era of nationally recognized cancer care.
MIAMI BEACH, FL — June 1, 2022 — Mount Sinai Medical Center welcomes Steven Hochwald, MD, MBA, FACS, as the inaugural director of the new Irma and Norman Braman Cancer Center, set to be completed in 2025. Dr. Hochwald will also serve as chief of surgical oncology and holds titles at Columbia University in New York, as part of Mount Sinai’s ongoing affiliation with the Ivy League institution.
A leading pancreatic and gastrointestinal surgical oncologist, and an avid researcher, Dr. Hochwald was recruited from Roswell Park Comprehensive Cancer Center in New York, an NCI-designated institution. Dr. Hochwald’s extensive research focuses on technical advances in minimally invasive upper gastrointestinal surgeries and on the development of new targets and agents for the treatment of pancreatic and gastroesophageal malignancies.
Dr. Hochwald brings over 30 years of clinical experience and research-focused expertise to Mount Sinai’s award-winning cancer program, which holds the only Ivy League affiliation of its kind in South Florida, backed by Columbia University.
“For over a decade, Mount Sinai’s partnership with Columbia University has provided enhanced expertise and care for the South Florida community,“ said Dr. Anil K. Rustgi, Director of the Columbia University Herbert Irving Comprehensive Cancer Center. “The addition of Dr. Hochwald and his research-driven expertise will further elevate the high-quality cancer care Mount Sinai delivers to its patients.”
Dr. Hochwald will usher in a new era of patient-focused care, as the medical center prepares for the building of the Braman Cancer Center on Mount Sinai’s main campus in Miami Beach. Dr. Hochwald is focused on expanding oncological services, such as adaptive radiation therapy and robotic surgeries. He will also lead the way in advancing technological resources and developing clinical trials and multidisciplinary clinics for cancer patients.
“We have the unique opportunity to elevate how cancer care is delivered to our community,” said Dr. Hochwald. “Our expert clinical team, in conjunction with the team at Columbia University, will create a conduit for additional innovation in cancer research, prevention, early detection, therapy, and survivorship, through personalized comprehensive care for our patients.”
A graduate of New York University School of Medicine, Dr. Hochwald received postgraduate training in surgical oncology at Memorial Sloan Kettering Cancer Center and completed an oncology research fellowship at the Memorial Sloan Kettering Cancer Center’s Surgical Metabolism Laboratory. He also earned an MBA at the University of Buffalo (SUNY) School of Management and an executive degree in managing health care delivery at Harvard Business School Executive Education.
During his time at Roswell Park Cancer Center, Dr. Hochwald created significant growth in endoscopy, GI, and endocrine surgery volume; provided leadership and direction for clinical growth; and increased efficiency and quality as the physician leader of all the GI services.
Dr. Hochwald’s work has been published in over 200 medical papers, 38 book chapters and invited manuscripts, and over 19 scholarly reviews. Dr. Hochwald has also led numerous research studies, which aim to help patients with complicated cancers.
“We have tremendous depth and breadth of expertise in our cancer program,” said Dr. Kfir Ben-David, Chairman of the Department of Surgery. “The addition of Dr. Steven Hochwald further expands our ability to deliver comprehensive, research-driven care to our patients.”
About the Irma and Norman Braman Cancer Center
The Irma and Norman Braman Cancer Center is expected to be completed in the first quarter of 2025. The building will occupy over 200,000 square feet, and it will support the medical center’s expert physicians in delivering leading-edge cancer care to all patients. The Braman Cancer Center will offer patients a multitude of support services to engage individuals and promote a holistic approach to their well-being. These services include nutrition classes, physical therapy, massage, meditation classes, a dedicated spa, and more.
“The Irma and Norman Braman Cancer Center will meet our community’s mounting need for more cancer treatment resources, more access to care and more expertise, providing an unmatched patient-centric experience,” said Gino R. Santorio, President and CEO of Mount Sinai Medical Center. “Together, with Dr. Hochwald, we are focused on continuing to expand our medical staff, adding new technologies and resources and expanding access for all.”
Dr. Hochwald will treat patients at Mount Sinai’s main campus in Miami Beach. To schedule an appointment, call 305.674.CARE. For more information on Mount Sinai Medical Center and the Mount Sinai Cancer Center, visit msmc.com.
About Mount Sinai Medical Center
Founded in 1949, Mount Sinai Medical Center is the largest independent, private, not-for-profit teaching hospital in South Florida. Mount Sinai’s Centers of Excellence combine technology, research, and academics to provide innovative and comprehensive care in cardiology, urology, neurology, oncology, and orthopedics. One of a select few statutory teaching hospitals in the state, Mount Sinai is the hospital of choice for those who seek the level of expertise and care that only a teaching hospital can offer. The medical center’s commitment to quality has garnered prestigious recognition, including designation as a comprehensive stroke center and providing some of the best heart attack and cardiac surgery survival rates in Florida.
